Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure, part III.2: Treatment of anaemia with iron (multiple letters) [3]

Nephrology Dialysis Transplantation

Volumn 20, Issue 7, 2005, Pages 1512-1514

  Vaage Nilsen, Odd ^a   Macdougall, Iain C ^b   Eckardt, Kai Uwe ^b   Horl, Walter ^b  

^a Nebo a/s   (Denmark)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COSMOFER; FERRIC HYDROXIDE SUCROSE; FERROUS GLUCONATE; IRON DERIVATIVE; IRON DEXTRAN; ANTIANEMIC AGENT; FERRIC ION;

ANAPHYLAXIS; ANEMIA; CHRONIC KIDNEY FAILURE; CYTOTOXICITY; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG SAFETY; HEART ARREST; HEMODIALYSIS; HUMAN; IN VITRO STUDY; IRON THERAPY; LETTER; LONG TERM CARE; MOLECULAR WEIGHT; OXIDATIVE STRESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT COURSE THERAPY; SIDE EFFECT; EUROPE; EVIDENCE BASED MEDICINE; NOTE;

ANEMIA; EUROPE; EVIDENCE-BASED MEDICINE; FERRIC COMPOUNDS; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; PRACTICE GUIDELINES;

EID: 26044443074     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh976     Document Type: Letter

References (0)